Jason Zemansky
Stock Analyst at Bank of America Securities
(4.83)
# 427
Out of 4,531 analysts
421
Total ratings
61.1%
Success rate
21.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Maintained: Hold | $217 | $205.99 | +5.34% | 13 | Jul 17, 2026 | |
| INSM Insmed | Maintained: Buy | $214 | $108.32 | +97.56% | 49 | Jul 16, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $29 | $22.80 | +27.19% | 33 | Jul 15, 2026 | |
| MDGL Madrigal Pharmaceuticals | Reiterated: Hold | $542 | $553.48 | -2.07% | 25 | Jul 13, 2026 | |
| LGND Ligand Pharmaceuticals | Maintained: Buy | $266 → $388 | $303.39 | +27.89% | 8 | Jul 9, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $101 | $81.38 | +24.11% | 35 | Jul 9, 2026 | |
| CYTK Cytokinetics | Maintained: Hold | $67 → $83 | $80.18 | +3.52% | 46 | Jun 16, 2026 | |
| RCKT Rocket Pharmaceuticals | Maintained: Buy | $10 | $3.44 | +190.70% | 18 | Jun 11, 2026 | |
| ABOS Acumen Pharmaceuticals | Maintained: Buy | $8 | $2.25 | +255.56% | 13 | Jun 11, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $37 → $42 | $32.13 | +30.72% | 15 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $59 | $56.71 | +4.04% | 28 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $10.86 | +176.24% | 38 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $10.64 | +87.97% | 16 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.11 | +184.36% | 4 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $12 | $13.32 | -9.91% | 11 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $32 | $9.77 | +227.53% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $27.37 | -8.66% | 36 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.368 | +1,802.17% | 19 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $59.59 | n/a | 2 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $15 → $12 | $4.20 | n/a | 4 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1 | $4.38 | n/a | 3 | Dec 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.05 | n/a | 2 | Nov 17, 2023 |
Biogen
Jul 17, 2026
Maintained: Hold
Price Target: $217
Current: $205.99
Upside: +5.34%
Insmed
Jul 16, 2026
Maintained: Buy
Price Target: $214
Current: $108.32
Upside: +97.56%
Syndax Pharmaceuticals
Jul 15, 2026
Maintained: Buy
Price Target: $29
Current: $22.80
Upside: +27.19%
Madrigal Pharmaceuticals
Jul 13, 2026
Reiterated: Hold
Price Target: $542
Current: $553.48
Upside: -2.07%
Ligand Pharmaceuticals
Jul 9, 2026
Maintained: Buy
Price Target: $266 → $388
Current: $303.39
Upside: +27.89%
BridgeBio Pharma
Jul 9, 2026
Maintained: Buy
Price Target: $101
Current: $81.38
Upside: +24.11%
Cytokinetics
Jun 16, 2026
Maintained: Hold
Price Target: $67 → $83
Current: $80.18
Upside: +3.52%
Rocket Pharmaceuticals
Jun 11, 2026
Maintained: Buy
Price Target: $10
Current: $3.44
Upside: +190.70%
Acumen Pharmaceuticals
Jun 11, 2026
Maintained: Buy
Price Target: $8
Current: $2.25
Upside: +255.56%
Tyra Biosciences
Jun 10, 2026
Reiterated: Buy
Price Target: $37 → $42
Current: $32.13
Upside: +30.72%
Jun 3, 2026
Maintained: Buy
Price Target: $59
Current: $56.71
Upside: +4.04%
Jun 3, 2026
Reiterated: Buy
Price Target: $30
Current: $10.86
Upside: +176.24%
Jun 3, 2026
Reiterated: Hold
Price Target: $20
Current: $10.64
Upside: +87.97%
Jun 3, 2026
Reiterated: Buy
Price Target: $6
Current: $2.11
Upside: +184.36%
Jun 3, 2026
Reiterated: Sell
Price Target: $12
Current: $13.32
Upside: -9.91%
Jun 3, 2026
Reiterated: Buy
Price Target: $34 → $32
Current: $9.77
Upside: +227.53%
Apr 21, 2026
Maintained: Hold
Price Target: $25
Current: $27.37
Upside: -8.66%
Feb 17, 2026
Reiterated: Buy
Price Target: $7
Current: $0.368
Upside: +1,802.17%
Oct 30, 2024
Maintained: Buy
Price Target: n/a
Current: $59.59
Upside: n/a
Mar 28, 2024
Reiterated: Sell
Price Target: $15 → $12
Current: $4.20
Upside: n/a
Dec 26, 2023
Maintained: Sell
Price Target: $1
Current: $4.38
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $15.05
Upside: n/a